Target Price | CHF293.93 |
Price | CHF242.80 |
Potential | 21.06% |
Number of Estimates | 15 |
15 Analysts have issued a price target Sonova 2026 . The average Sonova target price is CHF293.93. This is 21.06% higher than the current stock price. The highest price target is CHF350.00 44.15% , the lowest is CHF224.00 7.74% . | |
A rating was issued by 17 analysts: 4 Analysts recommend Sonova to buy, 11 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sonova stock has an average upside potential 2026 of 21.06% . Most analysts recommend the Sonova stock at Hold. |
Mar '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CHF | 3.63 | 3.85 |
2.98% | 6.25% | |
EBITDA Margin | 25.93% | 24.81% |
3.21% | 4.31% | |
Net Margin | 16.56% | 14.25% |
3.35% | 13.97% |
14 Analysts have issued a sales forecast Sonova 2025 . The average Sonova sales estimate is CHF3.9b . This is 3.96% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF3.9b 4.85% , the lowest is CHF3.8b 3.50% .
This results in the following potential growth metrics:
2024 | CHF3.6b | 2.98% |
---|---|---|
2025 | CHF3.9b | 6.25% |
2026 | CHF4.1b | 7.33% |
2027 | CHF4.4b | 6.25% |
2028 | CHF4.8b | 8.09% |
2029 | CHF4.9b | 3.17% |
11 Analysts have issued an Sonova EBITDA forecast 2025. The average Sonova EBITDA estimate is CHF956m . This is 4.32% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF1.0b 11.25% , the lowest is CHF759m 17.18% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF940m | 6.10% |
---|---|---|
2025 | CHF956m | 1.66% |
2026 | CHF1.1b | 12.51% |
2027 | CHF1.2b | 8.60% |
2028 | CHF1.3b | 13.54% |
2029 | CHF1.3b | 1.34% |
2024 | 25.93% | 3.21% |
---|---|---|
2025 | 24.81% | 4.31% |
2026 | 26.00% | 4.80% |
2027 | 26.58% | 2.23% |
2028 | 27.92% | 5.04% |
2029 | 27.42% | 1.79% |
11 Sonova Analysts have issued a net profit forecast 2025. The average Sonova net profit estimate is CHF549m . This is 2.72% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF605m 7.18% , the lowest is CHF481m 14.82% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF601m | 6.23% |
---|---|---|
2025 | CHF549m | 8.60% |
2026 | CHF665m | 21.18% |
2027 | CHF723m | 8.73% |
2028 | CHF838m | 15.87% |
2029 | CHF848m | 1.18% |
2024 | 16.56% | 3.35% |
---|---|---|
2025 | 14.25% | 13.97% |
2026 | 16.09% | 12.91% |
2027 | 16.46% | 2.30% |
2028 | 17.64% | 7.17% |
2029 | 17.30% | 1.93% |
Mar '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 10.08 | 9.21 |
6.23% | 8.63% | |
P/E | 26.35 | |
EV/Sales | 4.17 |
11 Analysts have issued a Sonova forecast for earnings per share. The average Sonova EPS is CHF9.21 . This is 2.75% lower than earnings per share in the financial year 2024. The highest EPS forecast is CHF10.15 7.18% , the lowest is CHF8.07 14.78% .
This results in the following potential growth metrics and future valuations:
2024 | CHF10.08 | 6.23% |
---|---|---|
2025 | CHF9.21 | 8.63% |
2026 | CHF11.16 | 21.17% |
2027 | CHF12.14 | 8.78% |
2028 | CHF14.06 | 15.82% |
2029 | CHF14.23 | 1.21% |
Current | 25.63 | 1.35% |
---|---|---|
2025 | 26.35 | 2.81% |
2026 | 21.75 | 17.46% |
2027 | 20.00 | 8.05% |
2028 | 17.26 | 13.70% |
2029 | 17.06 | 1.16% |
Based on analysts' sales estimates for 2025, the Sonova stock is valued at an EV/Sales of 4.17 and an P/S ratio of 3.75 .
This results in the following potential growth metrics and future valuations:
Current | 4.33 | 8.46% |
---|---|---|
2025 | 4.17 | 3.80% |
2026 | 3.88 | 6.83% |
2027 | 3.65 | 5.89% |
2028 | 3.38 | 7.49% |
2029 | 3.28 | 3.07% |
Current | 3.90 | 8.62% |
---|---|---|
2025 | 3.75 | 3.80% |
2026 | 3.50 | 6.83% |
2027 | 3.29 | 5.89% |
2028 | 3.05 | 7.48% |
2029 | 2.95 | 3.07% |
Analyst | Rating | Action | Date |
---|---|---|---|
REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Jan 06 2025 |
EQUITA SIM |
Hold
➜
Hold
|
Unchanged | Dec 10 2024 |
BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Nov 24 2024 |
HSBC |
Buy
➜
Buy
|
Unchanged | Nov 24 2024 |
RESEARCH PARTNERS AG |
Buy
➜
Buy
|
Unchanged | Nov 21 2024 |
Analyst Rating | Date |
---|---|
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Jan 06 2025 |
Unchanged
EQUITA SIM:
Hold
➜
Hold
|
Dec 10 2024 |
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Nov 24 2024 |
Unchanged
HSBC:
Buy
➜
Buy
|
Nov 24 2024 |
Unchanged
RESEARCH PARTNERS AG:
Buy
➜
Buy
|
Nov 21 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.